Invention Grant
- Patent Title: Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
-
Application No.: US14546886Application Date: 2014-11-18
-
Publication No.: US09765336B2Publication Date: 2017-09-19
- Inventor: Joseph Collard , Olga Khorkova Sherman
- Applicant: CuRNA, Inc.
- Applicant Address: US FL Miami
- Assignee: CuRNA, Inc.
- Current Assignee: CuRNA, Inc.
- Current Assignee Address: US FL Miami
- Agency: CuRNA, Inc.
- Agent Monte R. Browder
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; C07K14/505 ; C12Q1/68
Abstract:
Oligonucleotide compounds modulate expression and/or function of Erythropoietin (EPO) polynucleotides and encoded products thereof. Methods for treating diseases associated with Erythropoietin (EPO) comprise administering one or more oligonucleotide compounds designed to inhibit the EPO natural antisense transcript to patients.
Public/Granted literature
- US20150087695A1 TREATMENT OF ERYTHROPOIETIN (EPO) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO EPO Public/Granted day:2015-03-26
Information query
IPC分类:
